Collapse of the Global Order on Drugs

From UNGASS 2016 to Review 2019

Axel Klein|Blaine Stothard

Emerald

This book can be opened with

Hardback

9781787564886

28 September 2018

£76.99

eBook (PDF)

9781787564879

28 September 2018

£76.99

eBook (ePub)

9781787564893

28 September 2018

£76.99

Note on our eBooks and Audiobooks: you can read our eBooks (ePUB or PDF) and listen to audiobooks on the free Emerald Books app on iOS, Android, and desktop. Or read and listen on Emerald's online reader (ePUB eBooks and audiobooks only). To purchase a digital book you will need to create an account if you don’t already have one. After purchasing you will receive instructions on how to get started.

Description
Contents
Reviews
About

This book describes the events, activities and negotiations leading up to the 2016 UN General Assembly Special Session on international drug policy. A range of respected authors from International institutions, academia and civil society organisations detail the background to the negotiations and the outcome; and possible future scenarios for continued reform and change at the High Level Review in 2019. The chapters include consideration of the positions taken by blocs and nation-states at all points on the prohibition – reform continuum. Topics covered include discussions on the importance of human rights, access to essential medicines and the role played by cannabis in revealing the contradictions and divisions in both national and international contexts. The break-down of the previous international consensus on ‘the world drug problem’ is clearly described and analysed, as is the slow progress being made to the adoption of a human rights and health-based approach to currently illegal drugs. Consideration is also given to the nations and arguments which continue to defend prohibition and its repressive impacts on national populations, and the prioritising of geo-politics over population health this represents in practice. There are lessons and examples here for international politics and national policy reform.

Foreword; Michel Kazatchkine Introduction; Axel Klein and Blaine Stothard Chapter 1. The 2016 UNGASS on Drugs: A Catalyst for the Drug Policy Reform Movement; Ann Fordham Fordham and Heather Haase Chapter 2. The Death Penalty for Drug Offences: Pulling Back the Curtain to Expose a Flawed Regime; Gen Sander and Rick Lines Chapter 3. Measuring the ‘World Drug Problem’: 2019 and Beyond; David R. Bewley-Taylor and Marie Nougier Chapter 4. Improving Access to Internationally Controlled Essential Medicines in the Post-UNGASS, Agenda 2030 Framework; Katherine Irene Pettus Chapter 5. The Elephant in the Room: Cannabis in the International Drug Control Regime; Tom Blickman Chapter 6. Drug Policy in the Russian Federation: Do Control Policies Produce More Harm Than Drugs?; Mikhail Golichenko, Anya Sarang, Khalid Tinasti and Isabela Barbosa Chapter 7. Consensus and Contradictions in ASEAN: An Analysis of Southeast Asia at and After UNGASS 2016; Ricky Gunawan and Gloria Lai Chapter 8. Deconstructing the Islamic Bloc: The Middle East and North Africa and Pluralistic Drugs Policy; Maziyar Ghiabi Chapter 9. Breaking Ranks: Pioneering Drug Policy Protagonism in Uruguay and Bolivia; Jonas von Hoffmann Chapter 10. The Netherlands, Portugal and the Czech Republic: Political Perceptions and Legal Realities; Danilo Ballotta and Brendan Hughes Chapter 11. The European Union in Panglossian Stagnation; Caroline Chatwin Chapter 12. United States Drug Policy: Flexible Prohibition and Regulation; Zara Snapp and Jorge Herrera Valderrábano Chapter 13. West Africa; Leandre Banon and Maria-Goretti Loglo Chapter 14. Switzerland: Moving Towards Public Health and Harm Reduction; Frank Zobel and Larissa J. Maier Chapter 15. Epilogue; Mike Trace

Specialists in international law and drug policy discuss how tensions between the objectives, assumptions, and activities at the local level are tearing apart the landscape of international drug policy. Among their topics are the death penalty for drug offenses: pulling back the curtain to expose a flawed regime, measuring the World Drug Problem: 2019 and beyond, deconstructing the Islamic bloc: the Middle East and North Africa and pluralistic drugs policy, the European Union in panglossian stagnation, and Switzerland: moving towards public health and harm reduction.
- Annotation ©2018

Axel Klein is a researcher and project consultant with a long standing commitment to drug policy reform. Axel has headed the research and international units at DrugScope and been a trustee for Transform, two UK NGOs. is publications include The Khat Controversy: Stimulating the Debate on Drugs (2007), Caribbean Drugs: From Criminalization to Harm Reduction (2004), and Drugs and the World (2009). More recently Axel has published on cannabis cultivation and the anthropology of drugs. He has been the editor of journal Drugs and Alcohol Today since 2007.

Blaine Stothard is an educationalist and prevention specialist who came to drug policy through an advisory role in a London LEA at the time of the UK’s first national drug policy. He was active in the Healthy Schools programmes from 1998 to 2010 as an independent consultant, has worked on related policy development and implementation in the UK and Eastern Europe and was the external consultant for the Moscow-based schools drug education programme run by Project HOPE from 1998 to 2006. He has been the co-editor of Drugs and Alcohol Today since 2014.